
The Heart & Cholesterol Snapshot panel provides an in-depth look at cardiovascular health and cholesterol balance. By measuring homocysteine, apolipoprotein A1, and an advanced lipid panel, it helps identify inflammation, cholesterol particle patterns, and other risk factors that standard cholesterol tests may miss. This panel is valuable for assessing heart disease risk, guiding prevention strategies, and supporting long-term heart health.
ApoB measures the number of LDL particles, offering a more precise risk assessment for cardiovascular disease than LDL alone.
Tracks lipid levels and cardiovascular risk factors.
Identifies imbalances in kidney and liver function, cardiovascular markers, and reproductive hormones — helping you stay ahead of chronic conditions.
Adults aged 20+ as part of regular cardiovascular screening.
Individuals wanting to be more proactive about their health without relying on insurance.
Individuals managing chronic conditions.
The Advanced Lipid Panel, Cardio IQ goes beyond a standard cholesterol test by measuring not just total cholesterol, LDL, and HDL, but also the size, number, and types of cholesterol particles. This deeper analysis helps identify hidden cardiovascular risks that may not appear on a basic lipid panel. It’s especially valuable for people with a family history of heart disease, metabolic syndrome, or other risk factors who need a more precise picture of their heart health.
Homocysteine is an amino acid in the blood that, at elevated levels, can damage blood vessels and increase the risk of heart disease, stroke, and other vascular problems. Measuring homocysteine helps identify hidden cardiovascular risk, guide nutritional support (such as B-vitamin supplementation), and monitor certain metabolic or inflammatory conditions. It’s especially useful for individuals with a family history of heart disease or unexplained blood vessel issues.
Apolipoprotein A1 (ApoA1) is the main protein in HDL (“good”) cholesterol and plays a key role in transporting cholesterol away from the arteries to be removed from the body. Higher ApoA1 levels are generally linked to a lower risk of heart disease, while low levels may indicate an increased risk. Measuring ApoA1 provides a more precise understanding of heart health and helps guide personalized cholesterol and cardiovascular prevention strategies.